[MDGL] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
30-Apr-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -14.37%
YoY- -37.72%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 0 0 0 0 147 1,143 4,023 -
PBT -6,524 -20,707 -23,557 -20,728 -15,051 -11,401 -9,308 -5.74%
Tax 0 0 0 0 0 0 50 -
NP -6,524 -20,707 -23,557 -20,728 -15,051 -11,401 -9,308 -5.74%
Tax Rate - - - - - - - -
Total Cost 6,524 20,707 23,557 20,728 15,198 12,544 13,331 -11.21%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 0.00 0.00 0.00 0.00 -10,238.78 -997.46 -231.37 -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -37.03 -6.69 -9.65 -10.52 -9.35 -9.50 -8.26 28.37%
EPS Diluted -37.03 -6.69 -9.65 -10.52 -9.35 -9.50 -8.26 28.37%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.